Back to results
US 2025/0367267 A1Published application
Treating autoimmune diseases with insulin-like growth factor 1 receptor ligand conjugated to an agent
AssigneeLirum Therapeutics, Inc.
InventorMatthew HOBERMAN
Life of this patent
Estimating the term…
Abstract
The subject matter described herein provides methods for treating an autoimmune disease in a subject, comprising administering to the subject an effective amount of a conjugate that comprises an IGF-1R ligand, or portion or variant thereof, and a disease-modifying agent.
Claims39
A method for treating an autoimmune disease in a subject in need thereof, said method comprising administering to the subject a conjugate comprising an insulin-like growth factor 1 receptor (IGF-1R) ligand, or portion or variant thereof, and a disease-modifying agent.
Dependencies are inferred from the claim text.